Levomilnacipran

Pharm Company: * MSN LABORATORIES PRIVATE LTD
Category: Antidepressant

Levomilnacipran (brand name Fetzima) is an antidepressant which was approved in the United States in 2013 for the treatment of major depressive disorder (MDD) in adults.[1] It is the levorotatory enantiomer of milnacipran, and has similar effects and pharmacology, acting as a serotonin–norepinephrine reuptake inhibitor (SNRI).[4][5] Contents 1 Medical uses 1.1 Depression 2 Side effects 3 Pharmacology 3.1 Pharmacodynamics 3.2 Pharmaco... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Levomilnacipran 20 mg Oral Capsule, Extended Release
NDC: 65162-411
Labeler:
Amneal Pharmaceuticals LLC
Levomilnacipran 80 mg Oral Capsule, Extended Release
NDC: 65162-437
Labeler:
Amneal Pharmaceuticals LLC
Levomilnacipran 120 mg Oral Capsule, Extended Release
NDC: 65162-455
Labeler:
Amneal Pharmaceuticals LLC
Levomilnacipran 40 mg Oral Capsule, Extended Release
NDC: 65162-960
Labeler:
Amneal Pharmaceuticals LLC

Related Brands

Drugs with the same active ingredients